Antoinette C Robinson

Antoinette C. Robinson serves as a key procurement lead within the National Cancer Institute (NCI), part of the National Institutes of Health, where she manages complex acquisitions to support cutting-edge cancer research infrastructure. Her role centers on securing specialized technical services that enable genomic analysis, precision medicine development, and translational research capabilities. She routinely oversees contracts for custom software development, data analytics platforms, and high-performance computing solutions critical to the NCI’s mission of accelerating cancer diagnostics and therapeutics. Her acquisitions are strategically aligned with the Institute’s focus on scalable, secure, and interoperable research technologies. Robinson maintains a primary contracting relationship with Roche Diagnostics Corporation, a global leader in in vitro diagnostics and bioinformatics solutions. Her procurement pattern reflects a preference for established, high-capacity vendors with proven expertise in clinical data systems, laboratory information management, and AI-driven genomic analysis tools. While she collaborates with industry leaders, her approach prioritizes technical excellence and regulatory compliance over socioeconomic set-asides, consistently awarding contracts under full and open competition. Her contracting activity shows no use of set-aside programs such as 8(a), HUBZone, or SDVOSB, with 100% of awards issued under full and open competition. This reflects a mission-driven focus on acquiring the highest-caliber technical capabilities to meet the NCI’s urgent research demands, rather than socioeconomic targeting. Her approach underscores the critical need for rapid, scalable solutions in time-sensitive cancer research environments. Robinson’s procurement portfolio is exclusively focused on NAICS 541511 (Custom Computer Programming Services), indicating deep specialization in bespoke software development for biomedical research. She procures advanced computational tools, data integration pipelines, machine learning models, and secure cloud-based platforms tailored to large-scale genomic datasets and clinical trial analytics. Her expertise lies at the intersection of bioinformatics, data science, and regulated research IT systems.